Previously, we demonstrated that several TLRs are expressed on cord blood-derived USSC. Stimulation of USSC with TLR agonists resulted in a marked increase of IL-6 and IL-8 production. Interestingly, TNF was undetectable after TLR stimulation, which appeared to be a result of an inactivated TNF promoter in USSC. Here, we elaborate this study by demonstrating that although USSC do not produce TNF, they are susceptible to TNF stimulation, resulting in NF-B translocation and cytokine production. Additionally, we compared different stem cell sources for their ability to produce TNF. Interestingly, we found that the TNF promoter in BM-MSC is inactivated as well. Like USSC, they are able to respond to TNF stimulation, but they are not able to produce TNF, even not after LPS stimulation. This limited cytokine response in combination with the well-studied immunosuppressive properties of MSC makes these cells ideal for immune-suppressive treatment modalities such as graft-versus-host disease.
Introduction
USSC are cord blood-derived multipotent MSC [1, 2] . USSC and BM-MSC possess the potential to differentiate into multiple lineages, including bone, cartilage, liver, and neuronal-type cells [1, 3, 4] . A great potential for therapeutic use of these MSC is based on the observation that MSC are not only able to evade the immune system but that they can also suppress immune responses [2, [5] [6] [7] . Although cell-cell contact as well as the production of soluble factors seem to be involved in this process, the precise interplay between the reported factors underlying the immunosuppressive effect of MSC still remains to be fully clarified [8] .
TNF is a cytokine involved in systemic inflammation and is a member of a group of cytokines that stimulates the acutephase reaction. In response to inflammatory stimulation, macrophages or monocytes secrete TNF, thereby inducing apoptotic or necrotic cell death. Dysregulation and in particular, overproduction of TNF have been implicated in a variety of human diseases, as well as cancer [9] . All of these functional characteristics of TNF are executed through specific members of the TNFR superfamily [9, 10] . TNFR1 is expressed in most tissues and can be fully activated by the membrane-bound and soluble trimeric forms of TNF, whereas TNFR2 is found only in cells of the immune system and responds to the membranebound form of the TNF homotrimer. These receptors trigger several intracellular signaling pathways, most importantly, the IB kinase and MAPK cascades, which govern gene expression through NF-B and AP-1 transcription factors, respectively.
Previously, we have examined TLR function in USSC [2] . We found that stimulation of these cells with a small set of TLR agonists resulted in a significant increase of a limited number of cytokines. Stimulation of TLRs on various cell types, including macrophages and DC, inherently triggers production of TNF [11] . Interestingly, TNF was undetectable after TLR stimulation in USSC, which appeared to be a result of a methylated TNF promoter [2] . As MSC, isolated from different anatomical locations, show a different epigenetic makeup [12] , we analyzed MSC obtained from BM for their epigenetic silencing of their TNF promoter. Here, we elaborate on this by demonstrating that although USSC do not produce TNF, they are sensitive to TNF stimulation, as demonstrated by NF-B translocation and subsequent cytokine production. MSC, isolated from different anatomical places, display distinct differences [13] [14] [15] . Therefore, to investigate whether this observation is specific for USSC or represents a more general phenomenon in MSC, we compared different stem cell sources for their ability to produce TNF. Interestingly, the TNF promoter is also inactivated in BM-MSC. Similar to USSC, they are able to respond to TNF stimulation, but under no circumstances do these cells seem able to produce TNF. Therefore, we conclude that the disability to produce TNF is a shared phenomenon in MSC isolated from cord blood as well as BM. This limited cytokine response in combination with the well-studied immunosuppressive properties of MSC makes these cells ideal for immune-suppressive treatment modalities.
MATERIALS AND METHODS

Generation of USSC
USSC were generated and expanded according to Kögler et al. [1] . Three different USSC cell lines were created: USSC-DD, USSC-5016, and USSC-1105. All experiments described here were performed multiple times (at least three) with all USSC cell lines.
Generation of BM-MSC
After obtaining informed consent, BM from healthy donors was aspirated, and mononuclear cells were isolated after Ficoll centrifugation. Cells were expanded using FBS batches, which were selected for their potential to support MSC expansion. Three independent BM-MSC lines were isolated and used for each experiment. All three cell lines expressed MSC marker proteins (CD73, CD105, CD80, and HLA-I), did not express CD45 CD31, HLA-DR, and CD80, and were able to differentiate into adipocytes, osteoblasts, and chondrocytes. To minimize culture-induced changes, cells were used at low passage number at the risk of a small percentage of contaminating cells.
TLR4 expression in USSC
RNA was isolated from USSC using TRIzol Reagent (Invitrogen, Carlsbad, CA, USA). RNA was converted to cDNA using random hexamers. qPCRs were conducted with the Power SYBR Green mix (Applied Biosystems, Foster City, CA, USA). The relative quantities of the genes were calculated using GAPDH as a reference, using the formula: 2 [-(Ct GENE -Ct GAPDH )].
Flow cytometric analysis
Following fixation in ice-cold 4% PFA for 10 min, cells were washed and stained with hTLR4 (HM2086).
NF-B nuclear translocation
Cells were plated at a density of 8000 cells/cm 2 . Each agonist was titrated [i.e., Pam3Cys (EMC, Tübingen, Germany), poly(I:C) (Sigma, Taufkirchen, Germany), LPS (Sigma), flagellin (Invivogen, San Diego, CA, USA), fibroblast-stimulating lipopeptide 1 (EMC), R848, and CpG (Sigma)]. Stimulated cells were washed with PBS, fixed for 15 min with 4% PFA in PBS, and stored overnight at 4°C in PBS. The next day, cells were permeabilized using 0.1% Triton X-100 in PBS. Cells were incubated with the F-6 antibody against NF-B p65 (SC-8008, Santa Cruz Biotechnology, CA, USA). After washing, the cells were incubated with Alexa Fluor 488 goat antimouse IgG (Invitrogen, Molecular Probes). Unbound antibody was removed, and after dehydration, cells were mounted on glass slides using Mowiol (Sigma).
Cytokine expression
Cells were cultured with TLR agonists; Pam3Cys, 2 g/mL; poly(I:C), 20 g/mL; LPS, 200 ng/mL; flagellin, 5 g/mL; fibroblast-stimulating lipopeptide 1, 2 g/mL; R848, 10 g/mL; and CpG, 2 g/mL. Supernatant was collected after 4, 8, or 24 h, and IL-8 and TNF-␣ expression was determined by ELISA (R&D Systems, Minneapolis, MN, USA). Intracellular cytokines were detected after lysing the cells by snap-freezing. Lysates were cleared by centrifugation.
BS modification of genomic DNA
BS treatment was used to convert unmethylated cytosine residues in genomic DNA to uracil (see http://www.protocol-online.org/prot/ Protocols/Bisulfite-Modification-Conversion--of--DNA-3160.html). In short, genomic DNA was digested with EcoRI, and DNA was purified and resuspended in Tris-EDTA buffer. The DNA was added to a solution contain- ing sodium BS and hydroquinone. The DNA was purified with the NucleoSpin Extract II kit (Macherey-Nagel, Düren, Germany).
Methylation-specific restriction PCR
Methylation-specific primers that flank the critical NFAT-binding 3-binding site within the TNF promoter were designed (http://www.urogene.org/ methprimer/) [16] . Forward primer 5Ј-GTGTGTTTTTAATTTTTTA-AATTTT-3Ј in combination with the reverse primer 5Ј-CAACTACCTT-TATATATCCCTAAAAC-3Ј was used [17] . PCRs consisted of one cycle of 95°C for 5 min, 35 cycles of 30 s at 55°C, 30 s at 72°C, 30 s at 95°C, and one cycle at 72°C for 5 min. Purified PCR products were subjected to digestion with TaqI (New England Biolabs, Ipswich, MA, USA), which is methylation-insensitive and recognizes the sequence 5Ј-TCGA-3Ј.
Statistical analysis
With the SPSS 9.0 statistical software package, a one-way ANOVA test was used to test the probability of significant differences between samples. Post hoc evaluation was performed using the Bonferroni and Tukey Honestly Significant Difference correction. Statistical significance was set at P Ͻ 0.05.
RESULTS AND DISCUSSION
LPS stimulation does not lead to TNF production in BM-MSC
Previously, Kögler et al. [18] showed that unstimulated USSC produce a lot of cytokines but do not produce detectable levels of TNF. Furthermore, after stimulation with LPS, still no detectable levels of TNF could be observed in USSC [2] . This is in sharp contrast with other data showing that BM-MSC and adipose-derived stem cells start to produce high levels of TNF upon stimulation with LPS or other TLR ligands [19 -21] . Tomchuck et al. [19] report that hMSC secrete TNF upon LPS stimulation, and although this conclusion seems fair (see Fig.  3 , upper), they indicate (see Fig. 3 , lower) that LPS stimulation resulted in a much lower TNF production compared with the untreated control [19] . Moreover, it is well possible that hMSC behave different from murine MSC used by one of the groups [20] . The other group did not show TNF protein data but showed RT-PCR data [21] . Stimulation of TLRs on various cell types inherently triggers production of TNF [11, 22] . Therefore, to exclude differences in TNF production as a result of differences in TLR4 expression, we determined mRNA expression of TLR4 in three USSC and three BM-MSC cell lines. Cells were harvested at early and late passage numbers, and total RNA was isolated. qPCR analysis revealed that TLR4 is expressed in all stem cell isolates (Supplemental Fig. 1) . We found that TLR4 expression is increased during long-term culture, which is in accordance with literature studies [23] . Next, we investigated IL-8 production upon TLR4 activation using LPS. The USSC cell lines as well as the BM-MSC readily produce IL-8 upon LPS stimulation (Fig. 1A) and the BM-derived MSC (Fig. 1B) . Similar to USSC, very low to undetectable levels of TNF were found in these BM-MSC after 4, 8, or 24 h of stimulation with LPS (Fig. 1, lower graphs) .
TNF induces NF-B nuclear translocation in USSC and BM-MSC
Two receptors, TNFR1 (CD120a) and TNFR2 (CD120b), bind TNF. Figure 2 shows that TNFR1 is expressed on USSC and BM-MSC, and TNFR2 is not or at very low levels. To investigate whether the downstream TNF pathway is also affected in USSC and MSC, we performed NF-B translocation studies. Both cell types were stimulated with TNF, and NF-B localization was assayed in time using immunofluorescence and subse- 
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www.jleukbio.org quent confocal-scanning laser microscopy. As shown in Figure 3 , TNF induced NF-B translocation to the nucleus within 30 min in USSC as well as BM-MSC cell lines. The response to TNF was still present at 8 h but faded thereafter (Fig. 3) .
TNF stimulation leads to cytokine expression in USSC
To assess whether TNF stimulation and subsequent NF-B translocation initiate cytokine secretion, we analyzed expression in conditioned media from unstimulated and TNF-stimulated cells using a hIL-8 and TNF ELISA. After 1 h of TNF stimulation, cells were washed with PBS and incubated further with normal medium. After 3 h, 7 h, and 23 h, conditioned medium was harvested and analyzed for cytokine production. We observed up-regulation of IL-8 levels 24 h after TNF stimulation in USSC and 8 h after TNF stimulation in BM-MSC as compared with unstimulated cells (Supplemental Fig. 2 , upper graphs). Similar to LPS stimulation, very low or no detectable levels of TNF were found after TNF stimulation in USSC and BM-MSC isolates (Supplemental Fig. 2 , lower graphs). This indicates that USSC and BM-MSC are incapable of producing TNF under the circumstances tested here.
Very low TNF mRNA expression in BM-MSC
Previously, we have shown that USSC do not produce TNFmRNA, not even after TLR stimulation [2] . Here, we show that BM-MSC can produce extremely low amounts of TNFmRNA, and these amounts are much lower than the TNFmRNA content in iDC after TLR stimulation (Fig. 4A) . As a control, IL-8-mRNA is detectable in all cell types after TLR stimulation (Fig. 4A) . The values are printed above the bars. To exclude the possibility that TNF is produced in BM-MSC but that they are impaired in TNF secretion, the intracellular TNF protein content in LPS-stimulated BM-MSC was determined. Stimulated cells were lysed in PBS by freezing them at -80°C for 40 h. Although intracellular IL-8 was readily detectable in BM-MSC and iDC using this method, no intracellular TNF could be detected in BM-MSC (Fig. 4B) . As a positive control, we show that intracellular TNF protein can be detected in LPS-stimulated iDC (Fig. 4B) .
The TNF promoter is methylated in MSC
As no TNF protein in the supernatants of TLR-stimulated MSC was detected (Fig. 2) , we hypothesize that the promoter of TNF is silenced by methylation in these cells. Generally, the TNF promoter is not methylated and is in fact expressed at low but detectable levels in virtually all cell types of the hematopoietic system. However, in some primary and tumor cell lines, this promoter is repressed firmly by means of DNA methylation [24 -26] . To prove this hypothesis, methylationspecific primers were developed that flank the region in the TNF promoter, which is known to be required for its expression [27] [28] [29] . This region, which lies ϳ200 bp upstream of the transcription start site of the TNF gene, contains a so-called 3 site, which has been demonstrated recently to bind to the transcription factor NFAT [17] . In our previous study, BStreated genomic DNA from different USSC lines was amplified with methylation-specific primers and digested with TaqI. The majority of full-length PCR products of 183 bp was digested into two fragments of 141 bp and 42 bp, indicating that the TNF promoter in USSC is methylated and therefore, inactive in these cells [2] . Intriguingly, when BS-treated genomic DNA from three different BM-MSC donors was amplified and digested with TaqI, similar results were obtained, again indicating the presence of methylated cytosine residues (Fig. 5) . Importantly, this was irrespective of stimulation with LPS. In summary, these data, underscored by other published data [27] [28] [29] , indicate that TNF is not expressed in MSC as a result of the methylation of its promoter. Therefore, we think that our study about promoter methylation is stronger proof that BM-MSC, like USSC, are incapable of producing TNF. This is supported by Gupta et al. [22] , who show that BM-MSC do not produce TNF in response to LPS stimulation. Interestingly, the addition of MSC to LPS-stimulated macrophages even reduced the level of TNF in the cell supernatant when compared with LPS-stimulated macrophages cultured alone [22] . To prove further that the disability to produce TNF is a common phenomenon in BM-MSC, we also analyzed TNF production in a commercial hMSC cell line (Cambrex, Walkersville, MD, USA). Similar to our MSC isolates, this commercial MSC cell line did not produce TNF upon TLR stimulation either. The cells, however, did produce IL-8 upon TLR3 and TLR4 triggering, indicating that they are responsive to TLR stimuli. Despite the locked TNF promoter in BM-MSC, still very low amounts of TNF mRNA were detected in these cells after LPS stimulation (Fig. 4A ). This might reflect the heterogeneous nature of this MSC population, where a low number of cells in this population are responsible for TNF mRNA expression, or the extreme sensitivity of the qPCR tech- nique could explain the detection of the low TNF RNA amounts. Importantly, we show that despite TNF, mRNA is observed in these cells; this does not translate into detectable levels of (intracellular or extracellular) TNF protein. Another interesting study demonstrates that TNF is not normally synthesized by 3T3 cells, in response to LPS or any other known stimulus [26] . On the other hand, RAW 264.7 macrophages maintain the TNF gene in an accessible form and display an intact LPS signal transduction pathway [30 -32] . After fusion of the RAW 264.7 cell with a 3T3 cell, the TNF genes in the RAW cells are silenced permanently. They even adapt a methylation pattern similar to that of the 3T3 cell TNF locus [26] . It appears that the fusion of these two cell types activates a system that silences the TNF gene. Whether MSC are able to silence TNF expression in neighboring cells remains to be investigated but could serve as an intriguing mechanism by which stem cells can evade the immune system. Remarkably, our results are in line with other studies describing that MSC express the TRAIL receptor, a TNF family member, where expression of the TRAIL receptor did not make the cells responsive to TRAIL [33, 34] . bp (***)products. As a positive control, iDC were used to show that methylationspecific genomic PCR products derived from these cells are resistant to TaqI digestion, resulting in an active TNF promoter. As a negative control, USSC were used to show that methylation-specific genomic PCR products derived from these cells are sensitive to TaqI digestion, resulting in an inactive TNF promoter. SF marker, small fragment (100 bps ladder) marker.
